Cargando…
Hepatitis C in injection drug users: It is time to treat
Injection drug users (IDUs) are at risk of hepatitis C virus (HCV) infection, due to needle and syringe sharing. Chronic HCV infection is a major cause of liver-related morbidity and mortality but can be cured with antiviral treatment leading to sustained viral response (SVR). It is well demonstrate...
Autores principales: | Grassi, Alberto, Ballardini, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449413/ https://www.ncbi.nlm.nih.gov/pubmed/28611509 http://dx.doi.org/10.3748/wjg.v23.i20.3569 |
Ejemplares similares
-
Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs
por: Foschi, Francesco Giuseppe, et al.
Publicado: (2021) -
Hepatitis C reinfection in former and active injecting drug users in Belgium
por: Busschots, Dana, et al.
Publicado: (2021) -
Eradication of hepatitis C infection: The importance of targeting people who inject drugs
por: Hellard, Margaret, et al.
Publicado: (2014) -
MBL2 and Hepatitis C Virus Infection among Injection Drug Users
por: Brown, Elizabeth E, et al.
Publicado: (2008) -
Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon
por: Mahfoud, Ziyad, et al.
Publicado: (2010)